nine insulin-dependent diabetics with undetectable plasma c-peptide ( less than 0.05 nmol l-1 ) and without insulin antibodies ( insulin binding to igg less than 0.05 ul-1 ) received subcutaneous injections of 10 u 125i-labelled soluble human or porcine insulin in the thigh on 2 consecutive days .
C0006558
c-peptide
C0086418
human